Glaxo, Boehringer allow more copying of AIDS drugs
New York TimesGlaxoSmithKline Plc and unlisted German drugmaker Boehringer Ingelheim said Wednesday they had agreed to allow the widespread manufacture of cheap generic versions of their patented AIDS drugs in South Africa. In an out-of-court settlement with AIDS activists, the companies said they would grant more licenses to generic firms to produce and import antiretroviral (ARV) drugs which fight the spread of the HIV virus.
—Posted: December 10, 2003
More news headlines: This week | Last week | Search archive